Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
Author(s) -
Hiroaki Saito,
Akihiko Ozaki,
Toyoaki Sawano,
Yuki Shimada,
Tetsuya Tanimoto
Publication year - 2019
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2019.2834
Subject(s) - guideline , payment , conflict of interest , accounting , clinical practice , business , clinical oncology , family medicine , medicine , actuarial science , medical physics , finance , cancer , pathology
This cross-sectional study evaluates the payment type and distribution from pharmaceutical companies, as well as policy transparency for conflict of interest disclosures among clinical practice guideline authors in Japan.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom